Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

Figure 1 Concentrations of fecal calprotectin, CRP, ESR and AGP in the UC patients and the controls. UC (A): Ulcerative colitis (active phase); UC (I): Ulcerative colitis (inactive phase). ^aP < 0.05 vs the control, ^bP < 0.01 vs UC (I) and the control, ^cP > 0.05 vs the control, ^eP < 0.05 vs UC (I) and the control.

Figure 2 Concentrations of fecal calprotectin, CRP, ESR and AGP in UC and the DAI score of UC.

Figure 3 The ROC curve analysis on the abilities of calprotectin, CRP, ESR and AGP to make a difference between active UC and inactive UC.